Genetic Testing Menu


 

Genetic Tests:

Pharmacogenomics (PGx)

Pharmacogenomics is the study of genetic variations that influence an individual’s response to drugs. The ideal medications and doses a person should be taking can be determined through genetic testing instead of trial and error.

More Information

Hereditary Cancer (CGx)

Our next-generation sequencing test for hereditary cancer analyzes 45 genes associated with increased risk to develop cancer. We use deletion and duplication sequencing in our CGx methodology, which allows us to determine not only small insertions and deletions, but also larger structural changes, changes that are often pathogenic, and changes which other sequencing providers cannot detect.

More Information

Alzheimer’s, Parkinson's, & Dementia (ADP)

This panel examines your risk for developing neurodegenerative disease, including Alzheimer’s, dementia, and Parkinson’s. This test includes the genes linked with development of early-onset Alzheimer's.

More Information

Cardiomyopathy (CDM)

Cardiomyopathy, a disorder characterized by the disease of heart muscle, may occur due to an inherited cause. This test is best for those with a history of cardiology disorders, or with a family history of sudden cardiac death.

More Information

Familial Hypercholesterolemia (FH)

Familial Hypercholesterolemia is a genetic condition that causes high levels of LDL (bad) cholesterol. If left untreated, FH can lead to early heart attacks, stroke, and heart disease.

More Information

Diabetes and Obesity (DOW)

Next-generation sequencing of an individual's DNA can determine the patient’s root cause of diabetes and obesity. This test may also help tailor treatments to the patient’s genetic makeup.

More Information

Location
Lehigh Valley Genomics
320 Middletown Blvd, Suite 303B
Langhorne, PA 19047
Phone: 267-296-1325
Fax: 215-253-4110
Office Hours

Get in touch

267-296-1325